| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
20,890,000 |
| Market
Cap: |
37.18(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.59 - $8.51 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aadi Bioscience is a biopharmaceutical company focused on developing and commercializing precision therapies targeted to rare mutation-driven diseases. Co.'s primary drug product, FYARRO, is nab-sirolimus (sirolimus protein-bound particles for injectable suspension (albumin-bound)) for diseases driven by the mTOR pathway activation through mutations or deletions of specific genes such as Tuberous Sclerosis Complex 1 and 2. FYARRO is licensed to Co. by Abraxis BioScience, LLC, a wholly owned subsidiary of Bristol Myers Squibb Company, for various therapeutic areas including oncology, cardiovascular, and metabolic related diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
122,000 |
248,000 |
500,000 |
584,000 |
| Total Sell Value |
$252,439 |
$623,979 |
$2,056,681 |
$2,685,347 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
5 |
11 |
27 |
35 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Novartis Ag |
10% Owner |
– – • |
2019-04-03 |
4 |
S |
$0.96 |
$55,712 |
I/I |
(58,033) |
5,193,108 |
|
- |
|
| Novartis Ag |
10% Owner |
– – • |
2019-04-02 |
4 |
S |
$0.97 |
$50,201 |
I/I |
(51,754) |
5,251,141 |
|
- |
|
| Novartis Ag |
10% Owner |
– – • |
2019-04-01 |
4 |
S |
$0.95 |
$111,064 |
I/I |
(116,909) |
5,302,895 |
|
- |
|
| Novartis Ag |
10% Owner |
– – • |
2019-03-29 |
4 |
S |
$0.91 |
$57,421 |
I/I |
(63,100) |
5,419,804 |
|
- |
|
| Novartis Ag |
10% Owner |
– – • |
2019-03-28 |
4 |
S |
$0.94 |
$83,505 |
I/I |
(88,835) |
5,482,904 |
|
- |
|
| Novartis Ag |
10% Owner |
– – • |
2019-03-27 |
4 |
S |
$0.99 |
$50,242 |
I/I |
(50,749) |
5,571,739 |
|
- |
|
| Novartis Ag |
10% Owner |
– – • |
2019-03-26 |
4 |
S |
$1.01 |
$179,540 |
I/I |
(177,762) |
5,622,488 |
|
- |
|
| Satter Muneer A |
Director |
– • • |
2019-01-10 |
4 |
B |
$2.45 |
$58,442 |
I/I |
23,818 |
5,621,835 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2019-01-09 |
4 |
B |
$2.39 |
$47,876 |
I/I |
20,000 |
5,598,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2019-01-08 |
4 |
B |
$2.20 |
$43,972 |
I/I |
20,000 |
5,578,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2019-01-07 |
4 |
B |
$2.18 |
$43,558 |
I/I |
20,000 |
5,558,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2019-01-04 |
4 |
B |
$2.12 |
$42,396 |
I/I |
20,000 |
5,538,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2019-01-03 |
4 |
B |
$2.08 |
$41,508 |
I/I |
20,000 |
5,518,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2019-01-02 |
4 |
B |
$1.94 |
$38,838 |
I/I |
20,000 |
5,498,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2018-12-31 |
4 |
B |
$1.75 |
$34,900 |
I/I |
20,000 |
5,478,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2018-12-28 |
4 |
B |
$1.72 |
$34,372 |
I/I |
20,000 |
5,458,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2018-12-27 |
4 |
B |
$1.67 |
$33,410 |
I/I |
20,000 |
5,438,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2018-12-26 |
4 |
B |
$1.69 |
$33,854 |
I/I |
20,000 |
5,418,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2018-12-21 |
4 |
B |
$1.84 |
$36,870 |
I/I |
20,000 |
5,398,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2018-12-20 |
4 |
B |
$1.85 |
$36,984 |
I/I |
20,000 |
5,378,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2018-12-19 |
4 |
B |
$1.92 |
$38,384 |
I/I |
20,000 |
5,358,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2018-12-18 |
4 |
B |
$1.99 |
$39,856 |
I/I |
20,000 |
5,338,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2018-12-14 |
4 |
B |
$2.00 |
$40,094 |
I/I |
20,000 |
5,318,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2018-12-13 |
4 |
B |
$2.02 |
$40,308 |
I/I |
20,000 |
5,298,017 |
2.25 |
- |
|
| Satter Muneer A |
Director |
– • • |
2018-12-12 |
4 |
B |
$2.05 |
$40,938 |
I/I |
20,000 |
5,278,017 |
2.25 |
- |
|
138 Records found
|
|
Page 4 of 6 |
|
|
0.10 (5.32%) 
